20 jun: G-20 Leaders Paper Over Differences on Euro Zone
20 jun: News Ltd. Close To Deal On Consolidated Media Holdings-Report
20-06-2012 00:47:00

KKR's Shares Rally 7% after Partial Selldown on Alliance Boots

Relateret indhold

By Amy Or

NEW YORK--KKR & Co. (KKR) shares rallied 6.9% to $12.48 Tuesday after it announced a partial selldown of its stake in pharmacy-led health and beauty retailer Alliance Boots GmbH.

The rise was one of the largest one-day gains since KKR was listed on the New York stock exchange in July 2010.

U.S. drug-store retailer Walgreen Co. (WAG) said it will acquire a 45% stake in Alliance Boots in a $6.7 billion deal, allowing the famed buyout giant and two of its funds to profit handsomely on a prefinancial-crisis investment.

KKR bought Alliance Boots in 2007 in what was Europe's largest leveraged buyout at $2.45 billion. The investment returned a healthy 1.8 times KKR's original investment, in the form of cash and Walgreen shares.

But the benefit of the Alliance Boots windfall on individual funds is likely to be marred by market declines preceding the deal's announcement.

Goldman Sachs analyst Marc Irizarry said in a note Tuesday the gains are "likely somewhat offset by negative mark to market in the firm's private equity portfolio in the second quarter."

Continued turmoil over the European sovereign debt crisis and lingering concerns about slowing global growth have weighed on equity markets in the past two months. The Standard & Poor's 500 index has lost 3.6% so far this quarter, a far cry from the robust 17.7% gain in the first quarter.

While private companies often track public market movements, it is hard to gauge the extent of value depreciation among KKR's privately held portfolio companies, given variations on specific company fundamentals and, therefore, the impact on KKR funds' values.

Barclays PLC analysts, led by Roger Freeman, said this deal, together with a $566 million divestment from Dollar General Corp. (DG) shares earlier this month, "should go a long way towards enabling KKR to pay cash carry." Cash carry refers to a private equity firm's profits distributable to investors.

KKR's 2006 Fund (Overseas), which piggybacked on the fundraising success of the North America-focused 2006 Fund to raise money for overseas investments, is a major beneficiary of the Walgreen-Alliance Boots tie-up. It contributed about 60% of the capital for Alliance Boots, while the European Fund II put up $750 million and KKR $300 million of its own balance sheet for the deal.

The 2006 Fund is still suffering from markdowns on some investments made during the height of the subprime bubble. While the value of the fund as a whole was marked above cost, there were individual investments that were under water. The so-called "netting hole" has to be filled before fund investors can get cash profits.

The 2006 Fund was $125 million below cost, net of cash profits from sales or on other investments.

At the end of March, three of KKR's seven active private equity funds didn't generate cash carry upon exit on investments.

Executives said European Fund II, launched in 2005, and another fund that invested in Alliance Boots, was "marked just below cost."

As a firm, the Alliance Boots deal has a great bang for the buck for the private equity giant. KKR has put up $300 million of its own balance sheet in the Alliance Boots deal, meaning it will earn every cent of profit out of it.

Also, the deal and the option for Walgreen to buy the remainder of the company in about three years for approximately $9.5 billion in cash and stock excluded Alliance Boots' 25% minority interest in Swiss-listed health-care company Galenica, which now is worth over $1 billion at its current market price. KKR and Alliance Boots Chairman Stefano Pessina will now control the stake.

Write to Amy Or at amy.or@dowjones.com

(END) Dow Jones Newswires

June 19, 2012 18:47 ET (22:47 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Aktier/tendens: C20 går grøn åbning i møde med TDC i rampelyset

31-10-2014 08:23:33
De europæiske aktiemarkeder ventes fredag at åbne med plus på hele linjen, og det ventes at smitte af herhjemme.Fredag vil TDC få en dag i rampelyset, da det da..

Schouw/CEO: Har flere opkøb i kikkerten

30-10-2014 15:39:25
Industrikonglomeratet Schouw & Co. har appetit på yderligere opkøb til sine porteføljevirksomheder.Det siger selskabets administrerende direktør Jens Bjerg Søre..

Novo/S&P Capital: Hæver kursmål til 273 kr. fra 253 kr.

30-10-2014 13:03:29
Analytikerne hos S&P Capital IQ er blevet mere positivt stemt over for Novo Nordisk-aktien.I hvert fald hæver finanshuset kursmålet til 273 kr. fra tidligere 25..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Novo/Swedbank: Sænker anbefaling og kursmål
2
Coloplast Q4: Absolut ingen slinger i valsen
3
Danske Bank: Analytikere finpudser kursmål efter regnskab
4
Veloxis får væsentlig forsinkelse i USA
5
Asien: Overraskende japansk beslutning trækker kraftigt op

Relaterede aktiekurser

Walgreen Co 62,96 0,0% Aktiekurs uændret
KKR & Co L.P. Common Uni.. 21,43 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Relaterede selskaber
Få adgang til information og anbefalinger af relaterede selskaber med PLUS pakken.

Du får adgang til 7 værdifulde investorværktøjer til investering.

Klik her og læs mere om PLUS pakken.
Euroinvestor i andre lande: Euroinvestor.com | Euroinvestor.se | Euroinvestor.no | Euroinvestor.fr | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Copyright Euroinvestor A/S 2014  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
31. oktober 2014 10:51:43
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20141028.2 - EUROWEB2 - 2014-10-31 10:51:43 - 2014-10-31 10:51:43 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x